Literature DB >> 3001700

Epidermal growth factor regulates the expression of its own receptor.

A J Clark, S Ishii, N Richert, G T Merlino, I Pastan.   

Abstract

The epidermal growth factor (EGF) receptor gene is the cellular homolog of the avian erythroblastosis virus erbB oncogene. Control of EGF receptor expression determines cellular responsiveness to EGF and might play an important role in neoplastic development. Using RNA blot hybridization, we have found that exposure of human KB carcinoma cells to EGF results in elevated levels of EGF receptor mRNA. The phorbol ester 4 beta-phorbol 12-myristate 13-acetate also stimulates EGF receptor RNA accumulation. Immunoprecipitation of metabolically labeled (30 min) EGF receptor protein revealed that synthesis of new EGF receptor follows the increase in receptor RNA. Addition of cycloheximide together with EGF further enhances EGF receptor RNA accumulation. Results of nuclear runoff-transcription experiments suggest that the stimulatory effects of EGF and cycloheximide are most likely due to a posttranscriptional control mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001700      PMCID: PMC390918          DOI: 10.1073/pnas.82.24.8374

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors.

Authors:  L S Lee; I B Weinstein
Journal:  Science       Date:  1978-10-20       Impact factor: 47.728

2.  Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells.

Authors:  A Aharonov; R M Pruss; H R Herschman
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene.

Authors:  J M Depper; W J Leonard; C Drogula; M Krönke; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.

Authors:  G H Reem; N H Yeh
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

7.  Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines.

Authors:  Y H Xu; N Richert; S Ito; G T Merlino; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells.

Authors:  G T Merlino; S Ishii; J Whang-Peng; T Knutsen; Y H Xu; A J Clark; R H Stratton; R K Wilson; D P Ma; B A Roe; John Hunts; Nobuyoshi Shimizu; Ira Pastan
Journal:  Mol Cell Biol       Date:  1985-07       Impact factor: 4.272

9.  Biosynthesis of the epidermal growth factor receptor in A431 cells.

Authors:  E L Mayes; M D Waterfield
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

10.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  50 in total

1.  Negative autoregulation of the neu gene is mediated by a novel enhancer.

Authors:  X Y Zhao; M C Hung
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  Oscillations and patterns in spatially discrete models for developmental intercellular signalling.

Authors:  Steven D Webb; Markus R Owen
Journal:  J Math Biol       Date:  2003-10-27       Impact factor: 2.259

3.  Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.

Authors:  L Lehtola; M Nistér; E Hölttä; B Westermark; K Alitalo
Journal:  Cell Regul       Date:  1991-08

4.  Homologous down-regulation of the insulin receptor is associated with increased receptor biosynthesis in cultured human lymphocytes (IM-9 line).

Authors:  D G Rouiller; P Gorden
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  The mRNA expression of the human 1,25-dihydroxyvitamin D3 receptor and the c-myc protooncogene in cultured human keratinocytes.

Authors:  N M Hanafin; K S Persons; M F Holick
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-03       Impact factor: 2.416

6.  Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src.

Authors:  W J Wasilenko; M Nori; N Testerman; M J Weber
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

Review 7.  Control of receptor sensitivity at the mRNA level.

Authors:  B J Morris
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

8.  Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin.

Authors:  W A Dittman; T Kumada; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  A novel effect of EGF on mRNA stability.

Authors:  Y Jinno; G T Merlino; I Pastan
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

10.  Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.

Authors:  Ajay K Yadav; Jaclyn J Renfrow; Denise M Scholtens; Hehuang Xie; George E Duran; Claudia Bredel; Hannes Vogel; James P Chandler; Arnab Chakravarti; Pierre A Robe; Sunit Das; Adrienne C Scheck; John A Kessler; Marcelo B Soares; Branimir I Sikic; Griffith R Harsh; Markus Bredel
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.